Back to Results
First PageMeta Content
Antiandrogens / Oncology / Prostate cancer / Biology / Hsp90 / Heat shock protein / Cancer research / Galeterone / Medicine / Pyridines / Abiraterone


September 10, 2012 Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:
Add to Reading List

Open Document

File Size: 15,85 KB

Share Result on Facebook
UPDATE